(Q39987320)

16 September 2017

title

Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells (English)

1 reference

16 September 2017

Shengbao Li

1

1 reference

16 September 2017

Qiang Tong

2

1 reference

16 September 2017

Weguo Zhang

3

1 reference

16 September 2017

Qiang Wang

4

1 reference

16 September 2017

Zihua Chen

5

1 reference

16 September 2017

Qingming Wu

6

1 reference

16 September 2017

publication date

1 May 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

333-337

1 reference

Identification of a phorbol ester-repressible v-src-inducible gene

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Cyclooxygenase-2: a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Effects of adenovirus-mediated human cyclooxygenase-2 antisense RNA on the growth of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Cyclooxygenase-2: a therapeutic target in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Colorectal cancer chemoprevention: aspirin, other NSAID and COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

Aspirin and the Risk of Colorectal Cancer in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900701788056

10.1080/07357900701788056

21 January 2018

Identifiers

DOI

1 reference

release_at5ka5nzabdz5pt244setarism

16 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/at5ka5nzabdz5pt244setarism

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference